CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 229 filers reported holding CONMED CORP in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $322,418 | -25.8% | 3,197 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $434,441 | +30.4% | 3,197 | -0.4% | 0.02% | +23.1% |
| Q1 2023 | $333,287 | +17.2% | 3,209 | 0.0% | 0.01% | +18.2% |
| Q4 2022 | $284,446 | +10.7% | 3,209 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $257,000 | -16.3% | 3,209 | 0.0% | 0.01% | -15.4% |
| Q2 2022 | $307,000 | -35.9% | 3,209 | -0.5% | 0.01% | -27.8% |
| Q1 2022 | $479,000 | +4.8% | 3,225 | 0.0% | 0.02% | +5.9% |
| Q4 2021 | $457,000 | +8.3% | 3,225 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $422,000 | -4.7% | 3,225 | 0.0% | 0.02% | -5.6% |
| Q2 2021 | $443,000 | +4.7% | 3,225 | -0.3% | 0.02% | -5.3% |
| Q1 2021 | $423,000 | +16.9% | 3,236 | 0.0% | 0.02% | +18.8% |
| Q4 2020 | $362,000 | +42.0% | 3,236 | 0.0% | 0.02% | +33.3% |
| Q3 2020 | $255,000 | +9.4% | 3,236 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $233,000 | +24.6% | 3,236 | -0.9% | 0.01% | +8.3% |
| Q1 2020 | $187,000 | -48.3% | 3,266 | +0.9% | 0.01% | -40.0% |
| Q4 2019 | $362,000 | – | 3,236 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |